TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EQ

Equillium Inc

Healthcare · Biotechnology

1.90$ +1.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow EQ
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-55.4% -60.4% -46.3% -17,496.9%
0.7% 0.3% 0.3% 89.2%
30.7% 11.1% 9.1% 1,786.2%
179.4%
0.1% -7.1% 2.0% -1,782.3%
1.8% 0.1% 0.2% 36.9%
118.6% -13.2% 33.6% 3,433.8%
25.3%
0.0% -0.7% 0.4%
-9.1% -25.3% 0.0%
-7.7% -25.6% 0.4% 23,405.4%
55.5% -99.5% -12.5% 9,378.5%
-57.2% -60.5% -46.5% -17,533.8%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?